Italian asthma study tracks new biologic in real life
NCT ID NCT06948396
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study is collecting data from 315 patients in Italy who started treatment with tezepelumab for severe uncontrolled asthma. The goal is to describe their characteristics, medical history, and how their asthma exacerbation rates change over 12 to 24 months. It is not testing a new drug but gathering real-world information to better understand who benefits from this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tezepelumab
What this could lead to
If successful, this study could provide real-world evidence on how tezepelumab works in everyday patients, potentially improving treatment guidelines for severe asthma.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection or other factors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Cittadella (PD), Padova, Italy
-
Research Site
Montebelluna (TV), TV, Italy
-
Research Site
Aosta, Italy
-
Research Site
Avellino, Italy
-
Research Site
Bari, Italy
-
Research Site
Bergamo, Italy
-
Research Site
Brescia, Italy
-
Research Site
Cagliari, Italy
-
Research Site
Catania, Italy
-
Research Site
Catanzaro, Italy
-
Research Site
Civitanova Marche, Italy
-
Research Site
Ferrara, Italy
-
Research Site
Foggia, Italy
-
Research Site
Garbagnate(MI), Italy
-
Research Site
Genova, Italy
-
Research Site
Lamezia Terme, Italy
-
Research Site
Massa Carrara, Italy
-
Research Site
Milan, Italy
-
Research Site
Modena, Italy
-
Research Site
Naples, Italy
-
Research Site
Orbassano (TO), Italy
-
Research Site
Padova, Italy
-
Research Site
Reggio Emilia, Italy
-
Research Site
Roma, Italy
-
Research Site
Sassari, Italy
-
Research Site
Torino, Italy
-
Research Site
Tradate (VA), Italy
-
Research Site
Verona, Italy